According to Swedish Orphan Biovitrum's latest financial reports the company's total liabilities are $3.18 Billion USD. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | $3.18 B | -20.05% |
2023-12-31 | $3.98 B | 59.67% |
2022-12-31 | $2.49 B | -11.24% |
2021-12-31 | $2.81 B | -17.93% |
2020-12-31 | $3.42 B | 11.53% |
2019-12-31 | $3.07 B | 239.03% |
2018-12-31 | $0.90 B | 76.5% |
2017-12-31 | $0.51 B | 1.23% |
2016-12-31 | $0.50 B | 16.78% |
2015-12-31 | $0.43 B | 82.33% |
2014-12-31 | $0.23 B | -12.68% |
2013-12-31 | $0.27 B | 20.85% |
2012-12-31 | $0.22 B | -10.54% |
2011-12-31 | $0.25 B | -37.53% |
2010-12-31 | $0.40 B | 96.93% |
2009-12-31 | $0.20 B | 24.21% |
2008-12-31 | $0.16 B | 115.38% |
2007-12-31 | $76.72 M | -24.57% |
2006-12-31 | $0.10 B | -20.66% |
2005-12-31 | $0.12 B | -2.93% |
2004-12-31 | $0.13 B | 243.49% |
2003-12-31 | $38.44 M | 25.35% |
2002-12-31 | $30.67 M |